Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163017 · ClinicalTrials.gov registry record · NA
Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03163017 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 30 participants.
The verdict
NCT03163017, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if use of new imaging technology termed "3D fluoroscopy" will lead the surgeon to change the position of the fractured bones to a more accurate position.
Interventions
- DEVICE 2D Fluoroscopy
- DEVICE 3D Fluoroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03163017
The ClinicalTrials.gov registry entry for NCT03163017 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2D Fluoroscopy is the first listed.
NCT03163017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03163017 about?
NCT03163017 is a clinical study titled "Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury". The purpose of this study is to determine if use of new imaging technology termed "3D fluoroscopy" will lead the surgeon to change the position of the fractured bones to a more accurate position.
What is the current status of trial NCT03163017?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-03-01. Estimated completion is 2018-09-11.
What interventions are being tested in trial NCT03163017?
The interventions under investigation include: 2D Fluoroscopy (DEVICE), 3D Fluoroscopy (DEVICE).
Who is sponsoring clinical trial NCT03163017?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.